Evidence map›Paper›PMID 21252965›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2011

Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus.

R Rao, K Bryowsky, J Mao, D Bunton, C McPherson, A Mathur

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Patent ductus arteriosus and spontaneous intestinal perforation in a cohort of preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  6. Article
  7. Article
  8. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.Journal of perinatology : official journal of the California Perinatal Association · 2012
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

R RaoDivision of Newborn Medicine, Washington University in St Louis, St Louis, MO 63110, USA. rao_r@kids.wustl.edu
K Bryowsky
J Mao
D Bunton
C McPherson
A Mathur
St. Louis Children's Hospital · USWashington University in St. Louis · USSt. Clare Hospital in Lakewood · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo review intestinal complications associated with ibuprofen treatment of patent ductus arteriosus (PDA). STUDY

designData from preterm infants treated with ibuprofen were retrospectively reviewed. χ(2) test and Fischer's exact test were used for univariate analyses. Multivariate analyses with logistic regression modeling were used to identify risk factors.

resultOne hundred and two infants were treated with ibuprofen for PDA. Nine (9/102, 8.8%) infants developed spontaneous intestinal perforation (SIP), whereas 93/102 (91.2%) did not. The mean (± s.d.) gestational age (GA) at birth in infants with and without SIP was 25.2 (± 1.3) vs 27.6 (± 2.4) weeks (P=0.02) and the median (interquartile) length of stay (LOS) was 109.5 (91.0 to 116.5) vs 75.0 (53.0 to 94.5) days (P=0.002), respectively. The mean (± s.d.) age at starting ibuprofen was 3.3 (± 1.3) vs 5.8 (± 3.5) days in infants with and without SIP, respectively (P=0.03). In logistic regression analyses, increasing GA and later initiation of ibuprofen treatment were protective against risk of SIP; odds ratio, 95% confidence interval (OR, 95% CI)=0.26 (0.09 to 0.75), P=0.01 and 0.63 (0.41 to 0.95), P=0.03, respectively.

conclusionInfants at lower GA are at risk of SIP when treated early with ibuprofen for symptomatic PDA.

Indexed as

Infant, PrematureCohort StudiesConfidence IntervalsCyclooxygenase InhibitorsDose-Response Relationship, DrugDrug Administration ScheduleDuctus Arteriosus, PatentFemaleFollow-Up StudiesHumansIbuprofenIncidenceInfant, NewbornIntestinal PerforationLogistic ModelsMaleCyclooxygenase InhibitorsIbuprofen

Identifiers

PMID21252965
OpenAlexW2091390443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.